Healthcare utilization & disparities in pediatric diabetes care during COVID-19

ABSTRACT

Managing type 1 diabetes requires stringent management, frequent visits with medical providers, and regular screenings. The COVID-19 pandemic altered individuals’ interactions with medical providers and systems. The present study examined pediatric diabetes-related healthcare utilization during the first two years of the COVID-19 pandemic. Caregivers provided demographic and disease characteristics and completed the COVID-19 Exposure and Family Impact Scales (CEFIS) Exposure subscale. Medical information was retrospectively and prospectively extracted from the medical record. Multiple statistical analyses were conducted to describe healthcare utilization over time and to examine disparities. Participants did not meet recommendations for clinic attendance or glycemic health screening. Telehealth utilization differed by clinic location and across time. Location, income, and age were predictors of outcomes of interest. As COVID-19 infection fluctuates, healthcare providers and policymakers should provide consistent messaging to individuals with T1D and creatively encourage continuity of care. Clinical and policy recommendations are provided.

Disclosure statement

No potential conflict of interest was reported by the authors.

Data availability statement

The data that support the findings of this study are available from the corresponding author, Karen Dimentstein, MS, MPH, upon reasonable request.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.